(0.27%) 5 475.09 points
(0.13%) 39 170 points
(0.83%) 17 879 points
(0.07%) $83.44
(0.04%) $2.48
(0.17%) $2 342.90
(0.50%) $29.76
(0.51%) $993.70
(0.05%) $0.931
(0.15%) $10.66
(0.03%) $0.791
(-0.01%) $86.74
Live Chart Being Loaded With Signals
Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture...
Stats | |
---|---|
Today's Volume | 12 466 |
Average Volume | 11 339 |
Market Cap | 0.00 |
EPS | $-0.0949 ( Q3 | 2024-01-31 ) |
Last Dividend | $0.656 ( 2021-03-12 ) |
Next Dividend | $0 ( N/A ) |
P/E |
-6 265.00 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $0 (0.00%) |
Avid Bioservices, Inc. Correlation
10 Most Positive Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Avid Bioservices, Inc. Financials
Annual | 2023 |
Revenue: | $149.27M |
Gross Profit: | $31.48M (21.09 %) |
EPS: | $0.00900 |
FY | 2023 |
Revenue: | $149.27M |
Gross Profit: | $31.48M (21.09 %) |
EPS: | $0.00900 |
FY | 2022 |
Revenue: | $119.60M |
Gross Profit: | $36.65M (30.64 %) |
EPS: | $2.08 |
FY | 2021 |
Revenue: | $95.87M |
Gross Profit: | $29.31M (30.57 %) |
EPS: | $0.198 |
Financial Reports:
No articles found.
Avid Bioservices, Inc. Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
First Dividend | $0.299 | 2014-03-19 |
Last Dividend | $0.656 | 2021-03-12 |
Next Dividend | $0 | N/A |
Payout Date | 2021-04-01 | |
Next Payout Date | N/A | |
# dividends | 29 | -- |
Total Paid Out | $18.67 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 1.79 | -- |
Div. Sustainability Score | 0 | |
Div.Growth Potential Score | 0 | |
Div. Directional Score | 0 | -- |
Year | Amount | Yield |
---|
The company does not currently pay dividends. Given its current dividend status and a low Dividend Growth Potential Score (DGPS), there's minimal likelihood of dividends being initiated soon. Considering all factors, the near-term dividend outlook for the company remains unpromising.
Ex Date | Amount | Declaration Date | Record Date | Payment Date |
---|---|---|---|---|
12 Mar 2021 | $0.656 | 05 Mar 2021 | 15 Mar 2021 | 01 Apr 2021 |
11 Dec 2020 | $0.656 | 03 Dec 2020 | 14 Dec 2020 | 04 Jan 2021 |
11 Sep 2020 | $0.656 | 31 Aug 2020 | 14 Sep 2020 | 01 Oct 2020 |
12 Jun 2020 | $0.656 | 03 Jun 2020 | 15 Jun 2020 | 01 Jul 2020 |
13 Mar 2020 | $0.656 | 04 Mar 2020 | 16 Mar 2020 | 01 Apr 2020 |
13 Dec 2019 | $0.656 | 04 Dec 2019 | 16 Dec 2019 | 02 Jan 2020 |
13 Sep 2019 | $0.656 | 04 Sep 2019 | 16 Sep 2019 | 01 Oct 2019 |
14 Jun 2019 | $0.656 | 05 Jun 2019 | 17 Jun 2019 | 01 Jul 2019 |
15 Mar 2019 | $0.656 | 06 Mar 2019 | 18 Mar 2019 | 01 Apr 2019 |
14 Dec 2018 | $0.656 | 05 Dec 2018 | 17 Dec 2018 | 02 Jan 2019 |
14 Sep 2018 | $0.656 | 05 Sep 2018 | 17 Sep 2018 | 01 Oct 2018 |
15 Jun 2018 | $0.656 | 06 Jun 2018 | 18 Jun 2018 | 02 Jul 2018 |
16 Mar 2018 | $0.656 | 07 Mar 2018 | 19 Mar 2018 | 02 Apr 2018 |
15 Dec 2017 | $0.656 | 07 Dec 2017 | 18 Dec 2017 | 02 Jan 2018 |
15 Sep 2017 | $0.656 | 05 Sep 2017 | 18 Sep 2017 | 02 Oct 2017 |
15 Jun 2017 | $0.656 | 06 Jun 2017 | 19 Jun 2017 | 03 Jul 2017 |
16 Mar 2017 | $0.656 | 09 Mar 2017 | 20 Mar 2017 | 03 Apr 2017 |
14 Dec 2016 | $0.656 | 06 Dec 2016 | 16 Dec 2016 | 03 Jan 2017 |
14 Sep 2016 | $0.656 | 06 Sep 2016 | 16 Sep 2016 | 03 Oct 2016 |
15 Jun 2016 | $0.656 | 02 Jun 2016 | 17 Jun 2016 | 01 Jul 2016 |
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
OXLC | Dividend Diamond | 2024-09-16 | Monthly | 14 | 15.03% | 9.60 |
DMLP | Dividend Diamond | 2024-04-26 | Quarterly | 22 | 10.71% | 9.35 |
OXSQ | Dividend Diamond | 2024-09-16 | Monthly | 21 | 12.73% | 9.02 |
ARLP | Dividend Royal | 2024-05-07 | Quarterly | 26 | 9.67% | 8.87 |
PNNT | Dividend Royal | 2024-06-14 | Monthly | 18 | 9.49% | 8.82 |
MFIC | Dividend Royal | 2024-06-11 | Quarterly | 21 | 10.89% | 8.79 |
SPOK | Dividend Royal | 2024-05-23 | Quarterly | 20 | 8.73% | 8.72 |
PSEC | Dividend Royal | 2024-06-25 | Monthly | 21 | 9.03% | 8.65 |
SBLK | Dividend Royal | 2024-06-06 | Quarterly | 17 | 13.10% | 8.63 |
GBDC | Dividend Royal | 2024-11-29 | Bi-Monthly | 15 | 8.53% | 8.62 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | -0.131 | 1.500 | -2.62 | -3.93 | [0 - 0.5] |
returnOnAssetsTTM | -0.0394 | 1.200 | -1.312 | -1.574 | [0 - 0.3] |
returnOnEquityTTM | -0.0963 | 1.500 | -2.18 | -3.27 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 0.465 | 0.800 | -2.68 | -2.14 | [1 - 3] |
quickRatioTTM | 0.297 | 0.800 | -2.96 | -2.37 | [0.8 - 2.5] |
cashRatioTTM | 0.138 | 1.500 | -0.346 | -0.519 | [0.2 - 2] |
debtRatioTTM | 0.431 | -1.500 | 2.81 | -4.22 | [0 - 0.6] |
interestCoverageTTM | -10.85 | 1.000 | -5.13 | -5.13 | [3 - 30] |
operatingCashFlowPerShareTTM | 0.194 | 2.00 | 9.94 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | -0.608 | 2.00 | -0.304 | -0.608 | [0 - 20] |
debtEquityRatioTTM | 1.090 | -1.500 | 5.64 | -8.46 | [0 - 2.5] |
grossProfitMarginTTM | 0.0747 | 1.000 | -2.09 | -2.09 | [0.2 - 0.8] |
operatingProfitMarginTTM | -0.132 | 1.000 | -4.64 | -4.64 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.0627 | 1.000 | -0.763 | -0.763 | [0.2 - 2] |
assetTurnoverTTM | 0.300 | 0.800 | -1.331 | -1.065 | [0.5 - 2] |
Total Score | -0.942 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | -25.23 | 1.000 | -2.65 | 0 | [1 - 100] |
returnOnEquityTTM | -0.0963 | 2.50 | -1.402 | -3.27 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | -0.608 | 2.00 | -0.203 | -0.608 | [0 - 30] |
dividendYielPercentageTTM | 0 | 1.500 | 0 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 0.194 | 2.00 | 9.94 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | -0.831 | 1.500 | -8.87 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0900 | 1.000 | -0.250 | 0 | [0.1 - 0.5] |
Total Score | -0.681 |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Avid Bioservices, Inc.
Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. It produces monoclonal antibodies and recombinant proteins; and offers services, including CGMP clinical and commercial drug substance manufacturing, purification, bulk packaging, release and stability testing, and regulatory submission and support. The company also provides various process development services, such as upstream and downstream development and optimization, analytical methods development, testing, and characterization. It serves biotechnology and pharmaceutical companies. Avid Bioservices, Inc. has a process development and manufacturing agreement with Oragenics, Inc. to develop coronavirus vaccine. The company was formerly known as Peregrine Pharmaceuticals, Inc. and changed its name to Avid Bioservices, Inc. in January 2018. Avid Bioservices, Inc. was founded in 1981 and is headquartered in Tustin, California.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators